STARPHARMA HLDG.SP.ADR/10 (PQ6A) — Defensive Interval Ratio
STARPHARMA HLDG.SP.ADR/10 (PQ6A) has a Defensive Interval Ratio of 282 days as of June 2025. Defensive assets of €4.04 Million (cash €-, short-term investments €-, receivables €4.04 Million) cover 282 days of daily cash needs of €14.32K/day. Check STARPHARMA HLDG.SP.ADR/10 (PQ6A) tangible net worth to evaluate the tangible quality of the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
STARPHARMA HLDG.SP.ADR/10 Defensive Interval Ratio (2022–2025)
This chart shows how STARPHARMA HLDG.SP.ADR/10's Defensive Interval Ratio has evolved across 4 annual periods from 2022 to 2025. As of June 2025, the ratio stands at 282 days, meaning defensive assets of €4.04 Million can fund 282 days of operations without new revenue. Also explore STARPHARMA HLDG.SP.ADR/10 (PQ6A) net asset momentum to track the company's year-over-year net asset growth rate.
Annual Defensive Interval Ratio for STARPHARMA HLDG.SP.ADR/10 (2022–2025)
The table below presents the year-by-year Defensive Interval Ratio for STARPHARMA HLDG.SP.ADR/10 from 2022 to 2025, covering 4 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see how much is STARPHARMA HLDG.SP.ADR/10 worth.
| Year | DIR (days) | Defensive Assets (EUR) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 282 days | €4.04 Million | €14.32K/day | €- | €- | ▼ -52 days |
| 2024 | 334 days | €6.09 Million | €18.25K/day | €- | €- | ▲ +136 days |
| 2023 | 198 days | €7.86 Million | €39.65K/day | €- | €- | ▼ -62 days |
| 2022 | 260 days | €7.29 Million | €28.03K/day | €- | €- | — |